Center-Authored Papers

Filters: Author is Lin, Daniel W  [Clear All Filters]
2008
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR.  2008.  Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men.. Cancer causes & control : CCC. 19(1):25-31. Abstract
McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, Chan DW, Dahlgren J, Diaz J, Kagan J et al..  2008.  SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.. Clinical chemistry. 54(1):53-60. Abstract
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A et al..  2008.  Circulating microRNAs as stable blood-based markers for cancer detection.. Proceedings of the National Academy of Sciences of the United States of America. 105(30):10513-8. Abstract
Sim HG, Telesca D, Culp SH, Ellis WJ, Lange PH, True LD, Lin DW.  2008.  Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.. The Journal of urology. 179(5):1775-9. Abstract
Wright JL, Morgan TM, Lin DW.  2008.  Primary scrotal cancer: disease characteristics and increasing incidence.. Urology. 72(5):1139-43. Abstract
2009
Wright JL, Salinas CA, Lin DW, Kolb S, Koopmeiners J, Feng Z, Stanford JL.  2009.  Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.. The Journal of urology. 182(6):2702-7. Abstract
Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL et al..  2009.  Evaluation of the 8q24 prostate cancer risk locus and MYC expression.. Cancer research. 69(13):5568-74. Abstract
Schenk JM, Neuhouser ML, Lin DW, Kristal AR.  2009.  A dietary intervention to elicit rapid and complex dietary changes for studies investigating the effects of diet on tissues collected during invasive surgical procedures.. Journal of the American Dietetic Association. 109(3):459-63. Abstract
Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL.  2009.  Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.. The Prostate. 69(4):363-72. Abstract
Lin DW.  2009.  Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.. Urologic oncology. 27(3):315-21. Abstract
Takata Y, Morris SJ, King IB, Kristal AR, Lin DW, Peters U.  2009.  Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue.. The Prostate. 69(15):1635-42. Abstract
Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, Thompson IM.  2009.  Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.. The Prostate. 69(12):1303-11. Abstract
2010
Wright JL, Page ST, Lin DW, Stanford JL.  2010.  Male pattern baldness and prostate cancer risk in a population-based case-control study.. Cancer epidemiology. 34(2):131-5. Abstract
Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL.  2010.  Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.. The Journal of urology. 184(6):2303-7. Abstract
Newcomb LF, Brooks JD, Carroll PR, Feng Z, Gleave ME, Nelson PS, Thompson IM, Lin DW.  2010.  Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.. Urology. 75(2):407-13. Abstract
Wright JL, Kwon EM, Lin DW, Kolb S, Koopmeiners JS, Feng Z, Ostrander EA, Stanford JL.  2010.  CYP17 polymorphisms and prostate cancer outcomes.. The Prostate. 70(10):1094-101. Abstract
Wright JL, Dalkin BL, True LD, Ellis WJ, Stanford JL, Lange PH, Lin DW.  2010.  Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.. The Journal of urology. 183(6):2213-8. Abstract
Holt SK, Kwon EM, Lin DW, Ostrander EA, Stanford JL.  2010.  Association of hepsin gene variants with prostate cancer risk and prognosis.. The Prostate. 70(9):1012-9. Abstract
Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, Kratz M, Thompson IM.  2010.  Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 171(5):571-82. Abstract
Kristal AR, Price DK, Till C, Schenk JM, Neuhouser ML, Ockers S, Lin DW, Thompson IM, Figg WD.  2010.  Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.. The Prostate. 70(6):584-90. Abstract
Zeliadt SB, Hoffman RM, Etzioni R, Ginger VAT, Lin DW.  2010.  What happens after an elevated PSA test: the experience of 13,591 veterans.. Journal of general internal medicine. 25(11):1205-10. Abstract
Risk MC, Knudsen BS, Coleman I, Dumpit RF, Kristal AR, Lemeur N, Gentleman RC, True LD, Nelson PS, Lin DW.  2010.  Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(22):5414-23. Abstract
Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, Ostrander EA, Peters U, Stanford JL.  2010.  Vitamin D pathway gene variants and prostate cancer prognosis.. The Prostate. 70(13):1448-60. Abstract
2011
Wright JL, Neuhouser ML, Lin DW, Kwon EM, Feng Z, Ostrander EA, Stanford JL.  2011.  AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk.. The Prostate. 71(5):498-506. Abstract